Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients
Crossref DOI link: https://doi.org/10.1038/srep44674
Published Online: 2017-03-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Liang
Chi, Yayun
Xue, Jingyan
Ma, Linxiaoxi
Shao, Zhiming
Wu, Jiong
Text and Data Mining valid from 2017-03-15
Version of Record valid from 2017-03-15
Article History
Received: 8 November 2016
Accepted: 13 February 2017
First Online: 15 March 2017
Competing interests
: The authors declare no competing financial interests.